These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 26747037)

  • 21. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
    Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL
    JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease.
    van den Berg MJ; van der Graaf Y; Deckers JW; de Kanter W; Algra A; Kappelle LJ; de Borst GJ; Cramer MM; Visseren FLJ;
    Am Heart J; 2019 Jul; 213():112-122. PubMed ID: 31132583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
    Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus.
    Hillis GS; Woodward M; Rodgers A; Chow CK; Li Q; Zoungas S; Patel A; Webster R; Batty GD; Ninomiya T; Mancia G; Poulter NR; Chalmers J
    Diabetologia; 2012 May; 55(5):1283-90. PubMed ID: 22286552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults.
    Gellert C; Schöttker B; Müller H; Holleczek B; Brenner H
    Eur J Epidemiol; 2013 Aug; 28(8):649-58. PubMed ID: 23397516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
    de Galan BE; Zoungas S; Chalmers J; Anderson C; Dufouil C; Pillai A; Cooper M; Grobbee DE; Hackett M; Hamet P; Heller SR; Lisheng L; MacMahon S; Mancia G; Neal B; Pan CY; Patel A; Poulter N; Travert F; Woodward M;
    Diabetologia; 2009 Nov; 52(11):2328-2336. PubMed ID: 19688336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.
    Jónsdóttir LS; Sigfússon N; Gudnason V; Sigvaldason H; Thorgeirsson G
    J Cardiovasc Risk; 2002 Apr; 9(2):67-76. PubMed ID: 12006913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.
    Thomas MC; Woodward M; Li Q; Pickering R; Tikellis C; Poulter N; Cooper ME; Marre M; Zoungas S; Chalmers J;
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29960985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.
    Blomster JI; Chow CK; Zoungas S; Woodward M; Patel A; Poulter NR; Marre M; Harrap S; Chalmers J; Hillis GS
    Diabetes Obes Metab; 2013 Nov; 15(11):1008-12. PubMed ID: 23675676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study.
    Ohkuma T; Peters SAE; Jun M; Harrap S; Cooper M; Hamet P; Poulter N; Chalmers J; Woodward M;
    Diabetes Obes Metab; 2020 Oct; 22(10):1818-1826. PubMed ID: 32476250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial.
    Li Q; Chalmers J; Czernichow S; Neal B; Taylor BA; Zoungas S; Poulter N; Woodward M; Patel A; de Galan B; Batty GD;
    Diabetologia; 2010 Nov; 53(11):2320-7. PubMed ID: 20700576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes.
    Paul SK; Klein K; Majeed A; Khunti K
    J Diabetes; 2016 May; 8(3):354-62. PubMed ID: 25929583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
    Lowe G; Woodward M; Hillis G; Rumley A; Li Q; Harrap S; Marre M; Hamet P; Patel A; Poulter N; Chalmers J
    Diabetes; 2014 Mar; 63(3):1115-23. PubMed ID: 24222348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
    Blomster JI; Zoungas S; Chalmers J; Li Q; Chow CK; Woodward M; Mancia G; Poulter N; Williams B; Harrap S; Neal B; Patel A; Hillis GS
    Diabetes Care; 2014; 37(5):1353-9. PubMed ID: 24578358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.